Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
3.770
-0.105 (-2.71%)
At close: May 9, 2025, 4:00 PM
3.810
+0.040 (1.06%)
After-hours: May 9, 2025, 7:51 PM EDT
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $2.20 million as of May 9, 2025. Its market cap has decreased by -79.42% in one year.
Market Cap
2.20M
Enterprise Value
1.57M
1-Year Change
-79.42%
Ranking
Category
Stock Price
$3.77
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.48M to $2.20M, a decrease of -99.32%. That is a compound annual growth rate of -76.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 2.20M | -76.46% |
| Dec 31, 2024 | 9.34M | -88.50% |
| Dec 29, 2023 | 81.20M | -75.83% |
| Dec 30, 2022 | 335.90M | 3.73% |
| Dec 31, 2021 | 323.81M | 0.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |